An investigational anti-cancer vaccine will be paired with nivolumab to determine whether the combination therapy will improve survival in patients with the disease.
Patients with type 1 diabetes who received a generic vaccine had normal blood sugar levels 8 years later.
The 2017-2018 flu season was severe, resulting in 172 pediatric deaths across the country.
Summer vacations mean more questions on traveling. Prepare your patients with these simple tips.
A study published in The Consultant Pharmacist looks at the possibility that community pharmacies could increase pneumococcal vaccine uptake.
PaxVax, an independent specialty vaccine company, is developing the prophylaxis.
Pharmacies, and pharmacists across the nation need to be in a constant state of readiness for the next influenza pandemic outbreak.
Top news of the day from across the health care landscape.
Top news of the day from across the health care landscape.
Education efforts are underway to improve HPV vaccination rates.
Technicians in Idaho who undergo training are now able to adminster vaccines under the supervision of a pharmacist.
The recent resurgence of mumps in the United States may be linked to waning vaccine protection, according to a recent analysis.
In a session at APhA2018, the national president of the American Pharmacists Association Academy of Student Pharmacists, spoke about organizing events, such as a flu vaccine clinic or presentation.
The recipients of the 2018 APhA Immunization Champion Awards have been announced
When new vaccines enter the market, health care providers and patients always have questions about what to do.
In oral testimony before the US House Committee on Energy and Commerce Subcommittee on Oversight and Investigations, FDA Commissioner Scott Gottlieb, MD, urged immediate steps that can be taken to enhance the product of existing licensed influenza vaccines.
Despite signs that influenza activity is declining, overall activity remains elevated across most of the United States following this season’s peak in early February.
The question of whether a state has the right to institute a mandatory vaccination policy against human papillomavirus (HPV) for school children remains hotly disputed.
Human papillomavirus infection (HPV) is a known cause for virtually all cases of cervical and anal cancers and about 70% of oropharyngeal cancer cases.
As the margin between acquisition cost and sales price continues to narrow for traditional community pharmacy medication dispensing, many pharmacies are increasingly turning to service-based opportunities to improve their profitability.
Vaccinations are often given to protect populations whose immune systems are most vulnerable, but pharmacists are aware that some vaccinations are also important during the adolescent and young-adult years.
Pharmacists have long been considered among the most accessible and trusted health care advisers.
Human papillomavirus (HPV) consists of a group of more than 150 related viruses, some of which have been identified as causes of certain types of cancer.
The 9-valent human papillomavirus (HPV) recombinant vaccine (Gardasil 9, Merck & Company, Inc.) is indicated for women and men aged 9 to 26 years for the prevention of certain diseases, precancerous lesions, and genital warts caused by HPV.
